Validity and Reliability of the Self-administered Timed Up and Go Test: a Promising Telehealth Resource for Monitoring the Risk of Falls in Community-dwelling Older Adults
NCT ID: NCT06481384
Last Updated: 2024-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
37 participants
OBSERVATIONAL
2023-10-10
2024-05-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validity and Reliability of a Depth Camera-based Automated Physical Function and Fall Risk Assessments
NCT06519864
Fall Risk Prediction and Reduction in Community Ambulators 65 Years of Age or Older
NCT00884208
Comparison of Dual-Task Timed Up and Go Test (Cognitive) and 3-m Backwards Walk Test
NCT05211349
Evaluation of the Measurement Properties of a 5 Time Repeated Instrumented Timed Up and Go (5iTUG)
NCT03769220
Strategies for Preventing Falls in the Elderly
NCT06089213
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Variable: Self-Efficacy for Exercise This 5-item questionnaire intended to analyse the confidence that a person has to perform exercise according to 5 different emotional states, such as feeling worried or having problems, feeling depressed, feeling tired, feeling tense, and being busy.
Variable: Activities and Participation Profile Related to Mobility (PAPM) PAPM is an 18-item scale to assess the difficulties an individual experiences while performing certain daily activities in their natural environment, such as interactions and social relations, education, employment, money management, and social and community life and influence a person's active participation in society. It has a 5-point Likert scale from 0, meaning "no limitation or restriction," to 4, meaning "complete limitation or restriction." In between, 1 indicates "mild limitation or restriction," 2 indicates "moderate limitation or restriction," and 3 indicates "severe limitation or restriction" and since some activities may not apply, not all activities may be rated.
Functional tests Functional capacity was assessed using a set of three tests, also associated with the cited protocol. The 10-Meter Walking Speed (10-MWS) test, 30s Seconds Sit to Stand (30s STS) test and TUG test. These tests assess domains such as gait, balance, functional mobility, lower limb strength and fall risk.
Variable: 10-Meter Walking Speed test The 10-MWS test was used to calculate the speed of accelerated walking, without running, timed over a 10-metre course. This can be useful in identifying those who are at risk or in need of intervention. Performing this test requires a 20-meter course, with 5 meters of acceleration and 5 meters of deceleration and 10 meters for timed walking. Markings are made at 5, 10, 15 and 20 meters and the time between 5 and 15 meters is recorded. The person is instructed to walk at their fastest speed, wearing comfortable footwear and walking aids if necessary.
Variable:30 Seconds Sit to Stand The 30s STS test is a simple instrument used to assess lower limb strength and assess muscle weakness. The person is instructed to perform cycles of sitting and getting up from a chair as many times as possible for 30 seconds. At the end, the number of repetitions is recorded.
Variable: Timed up and Go test The TUG test evaluates dynamic balance, mobility and strength of the lower limbs. The test begins with the person sitting in a standard chair and is instructed to walk a 3-metre course, turn around and return to the chair and sit down, as quickly as possible, without running and without the aid of the upper limbs.
The participants were given a new informed consent to take part in the study and explained its purpose and procedure. Each one was measured in person by the physiotherapist (face-to-face assessment) and at home by the participant (self-administered assessment), 18 to 24 hours apart.
The face-to-face assessment was carried out by a physiotherapist. It should be noted that each participant performed a single TUG test and the result was recorded in seconds, to two decimal places.
The statistical analysis was carried out using IBM SPSS (Statistical Package for the Social Sciences) software, version 29.0.1.0 for Windows. The interpretation of statistical analysis tests was conducted on a significance level of 0.05 (p≤0.05), with a confidence interval of 95%. Pearson´s correlation (r) was used for the analysis of correlations. In the descriptive analysis of the variables, the data was presented according to the mean and standard deviation or percentage, whichever was more appropriate. Pearson´s correlation (r) was used for the analysis of correlations with the values: 0.9-1.0 very strong, 0.70-0.89 strong, 0.40-0.69 moderate, 0.10-0.39 weak and 0.00-0.19 negligible. The data was also presented in terms of its distribution, with a Q-Q graph and T-test for normality. For the TUG test, the minimum clinically acceptable limit of 5 seconds was used, as previously reported.
Firstly, the validity between the self-administered assessment and the simultaneous face-to-face assessment was determined using paired t-tests. For concurrent validity between the self-administered assessment and the separate face-to-face assessment, the Bland and Altman limit of agreement statistic was used. Values that were within the minimum clinically acceptable difference were considered valid and acceptable.
The validity of the assessment carried out by the participant at home was also established by comparing it with the separate face-to-face assessment, using the mean difference of assessments, paired t-tests and intra-class correlation coefficient (ICC).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Residents in the community;
* Present the ability to carry out screenings;
* The individual cannot know the result of the test carried out in person;
* The individual must agree to take the home test;
* Sign to participate in the study and sign the informed consent form.
Exclusion Criteria
* Residing in an institution;
* Not being able or unwilling to give informed consent prior to completing the questionnaire;
* People who demonstrate difficulties in understanding the indications for carrying out functional tests, raising doubts about their cognitive capacity/dementia/ and/or depression;
50 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anabela Correia Martins
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anabela Correia Martins
Principal Investigador
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Escola Superior de Tecnologia da Saúde de Coimbra
Coimbra, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
149/2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.